Some additional info was provided as follows:
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. SciClone Pha rmaceuticals next reports earnings on November 04, 2014.
To receive a free e-mail notification whenever SciClone Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
SciClone Pharmaceuticals just filed a General Statement of acquisition of beneficial ownership - Jan. 22, 2015
Wilson W. Cheung Jane Green Chief Financial Officer Investors/Media 650.358.3434 650.358.1447 Wcheung@Sciclone.Com Jgreen@Sciclone.Com - Jan. 6, 2015